Vigmed Holding AB brings forward publication of the interim report

The Board of Directors of Vigmed Holding AB (publ) has made a resolution to publish the interim report for January - September 2014 earlier than previously announced. The report will be published Friday 24 October 2014.

For further information contact:

Chairman of the board, Lennart Holm 46 70 630 8562 or CEO, Finn Ketler 46 42 600 5311

Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden, and has approximately 20 employees. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG) and has approximately 5 400 shareholders. Remium Nordic AB is the Company’s Certified Advisor.

Additional information such as company description, a video presentation and risk factors can be found on Vigmed’s website: www.vigmed.com/investor